RE:Doing some ddTRUL now is valued close to $2B. CURA at IPO price is valued at $4B. Now is trading at 40% discount to IPO price, so valued at $2.5B.
Any big difference here? TRUL operates in one state, and CURA operates in 12 states. Plus CURA has tons of capital to deploy from IPO raising. How about TRUL, not much money in hand to expand or need more dilutive financing to back it up.
Whose growth potential is higher or in other words who can grow faster? Btw, as you can see since IPO, CURA is opening new dispensaries on a weekly basis.
One year later, let's see who is the revenue king.